...
首页> 外文期刊>American Journal of Physiology >A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes.
【24h】

A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes.

机译:H9c2心肌细胞中β-肾上腺素受体介导的磷酸肌醇3-激酶激活的新信号通路。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Stimulation of cardiac beta-adrenergic receptors (beta-AR) activates both the G(s)- and G(i)-coupled signaling cascades, including the phosphoinositide 3 kinase (PI3K) pathway, that have important physiological implications. Multiple isoforms of PI3K exist in the heart. The goals of this study were to examine the intracellular signaling pathways linking beta-AR to PI3K and to identify the PI3K isoform mediating this transactivation in a cardiac context. Acute beta-AR stimulation with isoproterenol resulted in increased tyrosine kinase-associated PI3K activity and phosphorylation of Akt and p70S6K in H9c2 cardiomyocytes. Cotreatment with ICI-118,551, but not CGP-20712, abolished the increase in PI3K activity, suggesting a beta(2)-AR-mediated event. PI3K activation was also abrogated by cotreatment with pertussis toxin, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2, a selective Src-family tyrosine kinases inhibitor), or AG-1296 [selective platelet-derived growth factor receptor (PDGFR) inhibitor] but not with an inhibitor for protein kinase A, protein kinase C, Ras, adenylyl cyclase, epidermal growth factor receptor, or insulin-like growth factor-1 receptor. beta-AR stimulation induced an increase in tyrosine phosphorylation of PDGFR, which was abolished by inhibition of Src either by PP2 or small interfering RNA. Moreover, H9c2 cardiomyocytes stably transfected with a vector expressing a Gbetagamma sequestrant peptide derived from the COOH-terminus of beta-AR kinase-1 failed to activate PI3K after beta-AR stimulation, suggesting Gbetagamma is required for the transactivation. Furthermore, acute beta-AR stimulation in vivo resulted in increases in PDGFR-associated PI3K and PI3Kalpha isoform activities but not the activities of other isoforms (PI3Kbeta, -delta, -gamma) in adult mouse heart. Taken together, these data provide in vitro and in vivo evidence for a novel mechanism of beta-AR-mediated transactivation of cardiac PI3Kalpha via sequential involvement of Galpha(i)/Gbetagamma, Src, and PDGFR.
机译:刺激心脏β-肾上腺素受体(β-AR)激活G(s)和G(i)耦合的信号级联,包括磷酸肌醇3激酶(PI3K)途径,这具有重要的生理意义。心脏中存在PI3K的多种同工型。这项研究的目的是检查将β-AR与PI3K连接的细胞内信号通路,并确定在心脏环境中介导这种反式激活的PI3K亚型。异丙基肾上腺素对β-AR的急性刺激导致H9c2心肌细胞中酪氨酸激酶相关的PI3K活性增加以及Akt和p70S6K的磷酸化。与ICI-118,551(而不是CGP-20712)共同处理消除了PI3K活性的增加,表明存在beta(2)-AR介导的事件。通过与百日咳毒素,4-氨基-5-(4-氯苯基)-7-(叔丁基)吡唑洛尔[3,4-d]嘧啶(PP2,一种选择性的Src家族酪氨酸激酶抑制剂)共处理,也可以消除PI3K活化)或AG-1296 [选择性血小板衍生生长因子受体(PDGFR)抑制剂],但不与蛋白激酶A,蛋白激酶C,Ras,腺苷酸环化酶,表皮生长因子受体或胰岛素样生长因子-抑制剂结合使用1个受体。 β-AR刺激诱导PDGFR的酪氨酸磷酸化增加,而PP2或小干扰RNA抑制Src则消除了酪氨酸磷酸化。而且,用表达衍生自β-AR激酶-1的COOH-末端的Gbetagamma螯合剂肽的载体稳定转染的H9c2心肌细胞在β-AR刺激后不能激活PI3K,表明反式激活需要Gbetagamma。此外,体内的急性β-AR刺激导致成年小鼠心脏中PDGFR相关的PI3K和PI3Kalpha同种型活性增加,但其他同种型(PI3Kbeta,-δ,-γ)没有活性。两者合计,这些数据提供了通过顺序参与Galpha(i)/ Gbetagamma,Src和PDGFR的β-AR介导的心脏PI3Kalpha反式激活的新机制的体外和体内证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号